{"transactions":[{"id":1549655,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-03T20:59:50.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":291450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest and become exercisable on August 1, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":291450,"derivative":{"exercise_price":10.82,"expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":291450},"source":{"system":"sec-edgar","filing":"0000950170-24-041551","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684015/000095017024041551/ownership.xml","form_type":"4"}},{"id":1549654,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-04-03T20:59:50.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":69316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). 25% of the RSUs shall vest on September 5, 2024, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":69316,"source":{"system":"sec-edgar","filing":"0000950170-24-041551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684015/000095017024041551/ownership.xml","form_type":"4"}},{"id":1925305,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-05T20:27:19.000Z","date":"2023-04-03","kind":"exercise","planned":false,"acquired":false,"shares":7452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As of the date hereof, these stock options are vested and currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.03,"expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":7452},"source":{"system":"sec-edgar","filing":"0001062993-23-008770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323008770/form4.xml","form_type":"4"}},{"id":1925304,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-04-05T20:27:19.000Z","date":"2023-04-03","kind":"exercise","planned":false,"acquired":true,"shares":7452,"price":1.03,"value":7675.56,"ownership":{"direct":true},"balance_after":256535,"source":{"system":"sec-edgar","filing":"0001062993-23-008770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323008770/form4.xml","form_type":"4"}},{"id":1940310,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-23T23:31:37.000Z","date":"2023-03-23","kind":"exercise","planned":false,"acquired":false,"shares":220930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests 25% on April 1, 2020, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":7452,"derivative":{"exercise_price":1.03,"expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":220930},"source":{"system":"sec-edgar","filing":"0001062993-23-007574","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323007574/form4.xml","form_type":"4"}},{"id":1940309,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-23T23:31:37.000Z","date":"2023-03-22","kind":"exercise","planned":false,"acquired":false,"shares":65698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests 25% on April 1, 2020, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":228382,"derivative":{"exercise_price":1.03,"expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":65698},"source":{"system":"sec-edgar","filing":"0001062993-23-007574","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323007574/form4.xml","form_type":"4"}},{"id":1940308,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-23T23:31:37.000Z","date":"2023-03-21","kind":"exercise","planned":false,"acquired":false,"shares":63616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests 25% on April 1, 2020, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":294080,"derivative":{"exercise_price":1.03,"expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":63616},"source":{"system":"sec-edgar","filing":"0001062993-23-007574","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323007574/form4.xml","form_type":"4"}},{"id":1940307,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:31:37.000Z","date":"2023-03-23","kind":"sale","planned":false,"acquired":false,"shares":15597,"price":3.55,"value":55369.35,"ownership":{"direct":true},"balance_after":249083,"source":{"system":"sec-edgar","filing":"0001062993-23-007574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323007574/form4.xml","form_type":"4"}},{"id":1940306,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:31:37.000Z","date":"2023-03-23","kind":"exercise","planned":false,"acquired":true,"shares":220930,"price":1.03,"value":227557.9,"ownership":{"direct":true},"balance_after":264680,"source":{"system":"sec-edgar","filing":"0001062993-23-007574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323007574/form4.xml","form_type":"4"}},{"id":1940305,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:31:37.000Z","date":"2023-03-22","kind":"sale","planned":false,"acquired":false,"shares":65698,"price":3.7237,"value":244639.6426,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.57 to $3.79, inclusive."}],"balance_after":43750,"source":{"system":"sec-edgar","filing":"0001062993-23-007574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323007574/form4.xml","form_type":"4"}},{"id":1940304,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:31:37.000Z","date":"2023-03-22","kind":"exercise","planned":false,"acquired":true,"shares":65698,"price":1.03,"value":67668.94,"ownership":{"direct":true},"balance_after":109448,"source":{"system":"sec-edgar","filing":"0001062993-23-007574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323007574/form4.xml","form_type":"4"}},{"id":1940303,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:31:37.000Z","date":"2023-03-21","kind":"sale","planned":false,"acquired":false,"shares":63616,"price":3.7706,"value":239870.4896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.935, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":43750,"source":{"system":"sec-edgar","filing":"0001062993-23-007574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323007574/form4.xml","form_type":"4"}},{"id":1940302,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:31:37.000Z","date":"2023-03-21","kind":"exercise","planned":false,"acquired":true,"shares":63616,"price":1.03,"value":65524.48,"ownership":{"direct":true},"balance_after":107366,"source":{"system":"sec-edgar","filing":"0001062993-23-007574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323007574/form4.xml","form_type":"4"}},{"id":2030774,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-06T23:50:32.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":131250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":131250,"derivative":{"exercise_price":4.64,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":131250},"source":{"system":"sec-edgar","filing":"0001062993-23-002309","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323002309/form4.xml","form_type":"4"}},{"id":2030773,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-06T23:50:32.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":131250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":131250,"derivative":{"exercise_price":4.64,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":131250},"source":{"system":"sec-edgar","filing":"0001062993-23-002309","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323002309/form4.xml","form_type":"4"}},{"id":2030772,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-06T23:50:32.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the \"Company's\") common stock. The RSUs vest 25% on February 2, 2024 and the remaining 75% vest on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock."}],"balance_after":43750,"source":{"system":"sec-edgar","filing":"0001062993-23-002309","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323002309/form4.xml","form_type":"4"}},{"id":2030771,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-06T23:50:32.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the \"Company's\") common stock. The RSUs vest 25% on February 2, 2024 and the remaining 75% vest on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock."}],"balance_after":21875,"source":{"system":"sec-edgar","filing":"0001062993-23-002309","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323002309/form4.xml","form_type":"4"}},{"id":2424110,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-27T21:50:48.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":105000,"derivative":{"exercise_price":13.15,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001062993-22-001688","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299322001688/form4.xml","form_type":"4"}},{"id":4404689,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research"}}],"security":"Common Stock","published_at":"2017-03-03T13:29:09.000Z","date":"2017-03-01","kind":"tax_withholding","acquired":false,"shares":18084,"price":44.77,"value":809620.68,"ownership":{"direct":true},"balance_after":64888,"source":{"system":"sec-edgar","filing":"0001209191-17-017109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919117017109/doc4.xml","form_type":"4"}},{"id":4459702,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-02-09T19:23:50.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the option vest at a rate of one forty-eighth (1/48th) per month beginning on March 7, 2017, provided the reporting person provides services to Five Prime Therapeutics, Inc. through each such date."}],"balance_after":25000,"derivative":{"exercise_price":45.38,"expiration_date":"2027-02-06","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-009276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919117009276/doc4.xml","form_type":"4"}},{"id":4459701,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research"}}],"security":"Common Stock","published_at":"2017-02-09T19:23:50.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":7031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on February 5, 2019 and two-thirds (2/3) of the restricted stock will vest on February 5, 2020, provided the reporting person provides services to Five Prime Therapeutics, Inc. through each such date."}],"balance_after":82972,"source":{"system":"sec-edgar","filing":"0001209191-17-009276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919117009276/doc4.xml","form_type":"4"}},{"id":4459700,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research"}}],"security":"Common Stock","published_at":"2017-02-09T19:23:50.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 5, 2018, 2019 and 2020, provided the reporting person provides services to Five Prime Therapeutics, Inc. through each such date."}],"balance_after":75941,"source":{"system":"sec-edgar","filing":"0001209191-17-009276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919117009276/doc4.xml","form_type":"4"}},{"id":4498913,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research"}}],"security":"Common Stock","published_at":"2017-01-05T14:20:23.000Z","date":"2017-01-03","kind":"tax_withholding","acquired":false,"shares":1306,"price":48.6,"value":63471.6,"ownership":{"direct":true},"balance_after":70316,"source":{"system":"sec-edgar","filing":"0001209191-17-001835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919117001835/doc4.xml","form_type":"4"}},{"id":4605902,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-12T20:25:51.000Z","date":"2016-09-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares underlying the option will vest monthly beginning on October 8, 2016."}],"balance_after":25000,"derivative":{"exercise_price":49.54,"expiration_date":"2026-09-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-16-141001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919116141001/doc4.xml","form_type":"4"}},{"id":4605901,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":92271,"kind":"person","name":"Borges Luis","position":1,"cik":"0001684015","reported_name":"Borges Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research"}}],"security":"Common Stock","published_at":"2016-09-12T20:25:51.000Z","date":"2016-09-08","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of September 1, 2017, 2018 and 2019."}],"balance_after":71622,"source":{"system":"sec-edgar","filing":"0001209191-16-141001","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919116141001/doc4.xml","form_type":"4"}}]}